Medicine & Health

Adults with a history of cancer are less likely to be physically active than those without a cancer history, finds a new study from Washington University in St. Louis.

WashU Medicine researchers found that dozens of blood proteins shifted during treatment with the anti-amyloid medication lecanemab, which could enable future blood tests monitoring a person’s response to the drug.

WashU Medicine allergist and immunologist Maya Jerath, MD, PhD, has treated over 650 patients with alpha-gal, a potentially life-threatening allergic reaction triggered by tick bites — and the prevalence is increasing rapidly, she says.

The Brown School’s Vanessa Fabbre discusses the field of queer gerontology and why supporting the researchers who study LGBTQ+ aging is an important part of the work.

The FTC’s deals with major drug middlemen may not do enough to lower what patients and employers pay for prescription drugs, said WashU Law’s Rachel Sachs.

September is Suicide Prevention Month, and WashU expert Ryan Lindsay is emphasizing a simple message: You don’t have to be a mental health professional to help someone who may be struggling.

Sara Malone and Lindsay Stark, both of WashU Bursky Public Health, become inaugural faculty scholars of the Ryan Institute for Interdisciplinary Health Solutions.Their projects will examine housing as a health intervention and improve transitions from pediatric to adult care for children with chronic illnesses.

A new Transcend Initiative seeks to address and fight life-threatening mycobacterial infections.

WashU Medicine researchers found that bacteria-infecting viruses and bacterial antibiotic resistance genes in the gut microbiomes of premature babies play an important role in necrotizing enterocolitis, a sudden and often fatal intestinal illness.

David M. Holtzman, MD, of WashU Medicine, was recognized by the National Institute of Neurological Disorders and Stroke for impactful mentorship of future scientists.